Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US45257L1089
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG002WD6SY6
IMMP
Immutep Limited
GICS: Health Care · SECTOR: Healthcare · SUB-SECTOR: Biotechnology · THEMEFOLIO: $HLTH
NAME
Immutep Limited
ISIN
US45257L1089
TICKER
IMMP
MIC
XNAS
REUTERS
IMMP.OQ
BLOOMBERG
IMMP US
Sat, 25.04.2026       Immutep
US45257L1089

NEW YORK, April 25, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Thu, 23.04.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - April 23, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public.SO WH...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Wed, 22.04.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - April 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public.SO WH...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Mon, 20.04.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - April 20, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public.SO WH...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Mon, 20.04.2026       Immutep
US45257L1089

NEW YORK, April 20, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Thu, 16.04.2026       Immutep
US45257L1089

NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Wed, 15.04.2026       Immutep
US45257L1089

Immutep Stock Collapsed Up to 90% After Independent Committee Recommended Halting Lead Phase III Trial -- Levi & Korsinsky Investigates Potential Securities Law Violations NEW YORK, April 15, 2026 /PRNewswire/ -- Immutep Ltd. (NASDAQ: IMMP) shares lost approximately 80% to 90% of their value after the company disclosed that an Independent Dat...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Tue, 14.04.2026       Immutep
US45257L1089

NEW YORK, April 14, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Fri, 10.04.2026       Immutep
US45257L1089

NEW YORK, April 9, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations t...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Thu, 09.04.2026       Immutep
US45257L1089

NEW YORK, April 9, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Tue, 07.04.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - April 7, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public.SO WHA...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Mon, 06.04.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - April 6, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Immutep Limited (NASDAQ:IMMP) ("Immutep Limited") concerning potential violations of the federal securities laws.On January 30, 2026, Immutep filed a 6-K with the SEC stating that the TACTI-004 futilit...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Sat, 04.04.2026       Immutep
US45257L1089

NEW YORK, April 4, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Fri, 03.04.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - April 3, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep Ltd. may have issued materially misleading business information to the investing pub...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Thu, 02.04.2026       Immutep
US45257L1089

NEW YORK, April 2, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Wed, 01.04.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - April 1, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep Ltd. may have issued materially misleading business information to the investing public.S...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Wed, 01.04.2026       Immutep
US45257L1089

Immutep Stock Collapsed Up to 90% After Independent Committee Recommended Halting Lead Phase III Trial -- Levi & Korsinsky Investigates Potential Securities Law Violations NEW YORK, April 1, 2026 /PRNewswire/ -- Immutep Ltd. (NASDAQ: IMMP) shares lost approximately 80% to 90% of their value after the company disclosed that an Independent Data...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Mon, 30.03.2026       Immutep
US45257L1089

NEW YORK, March 30, 2026 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Mon, 30.03.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - March 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Immutep Limited ("Immutep Limited") (NASDAQ: IMMP) concerning potential violations of the federal securities laws.On January 30, 2026, Immutep filed a 6-K with the SEC stating that the TACTI-004 futility analys...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Mon, 30.03.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - March 29, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public.SO WH...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Thu, 26.03.2026       Immutep
US45257L1089

NEW YORK, March 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Wed, 25.03.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - March 25, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public.SO WH...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Wed, 25.03.2026       Immutep
US45257L1089

Immutep Stock Collapsed Up to 90% After Independent Committee Recommended Halting Lead Phase III Trial -- Levi & Korsinsky Investigates Potential Securities Law Violations NEW YORK, March 25, 2026 /PRNewswire/ -- Immutep Ltd. (NASDAQ: IMMP) shares lost approximately 80% to 90% of their value after the company disclosed that an Independent Dat...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Tue, 24.03.2026       Immutep
US45257L1089

NEW YORK, March 24, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from al...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Mon, 23.03.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - March 23, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Immutep Limited (NASDAQ: IMMP) ("Immutep Limited") concerning potential violations of the federal securities laws.On January 30, 2026, Immutep filed a 6-K with the SEC stating that the TACTI-004 futil...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Mon, 23.03.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - March 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public....
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Sat, 21.03.2026       Immutep
US45257L1089

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Immutep Limited (“Immutep” or “the Company”) (NASDAQ: IMMP) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disc...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Thu, 19.03.2026       Immutep
US45257L1089

NEW YORK, March 19, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Immutep Limited ("Immutep" or the "Company") (NASDAQ: IMMP).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980....
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Wed, 18.03.2026       Immutep
US45257L1089

Immutep Reported TACTI-004 Futility Analysis Was "On Track" in January 2026 -- Weeks Later the Trial Was Halted After Failing to Meet Efficacy EndpointsNEW YORK, March 18, 2026 /PRNewswire/ -- Shareholders of Immutep Ltd. (NASDAQ: IMMP) who lost money are urged to act now. On January 30, 2026, Immutep filed a 6-K stating that completion of the fut...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Wed, 18.03.2026       Immutep
US45257L1089

NEW YORK, March 18, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from al...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Tue, 17.03.2026       Immutep
US45257L1089

Why: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Immutep Ltd. (NASDAQ: IMMP) resulting from allegations that Immutep may have issued materially misleading business information to the investing public. So What: If you purchased Immutep securities yo...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Tue, 17.03.2026       Immutep
US45257L1089

New York, New York--(Newsfile Corp. - March 17, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Immutep Limited ("Immutep Limited") (NASDAQ: IMMP) concerning potential violations of the federal securities laws.On January 30, 2026, Immutep filed a 6-K with the SEC stating that the TACTI-004 futility analys...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Fri, 06.03.2026       Immutep
US45257L1089

Instrument ID [8545] (YP1A - US45257L1089) suspended...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink
Mon, 03.06.2024       Immutep
US45257L1089

Instrument ID [8545] (YP1A - US45257L1089) suspended...
Read more
Immutep
Technical Analysis Termsheets Terminal
Permalink